Neovacs (ALNEV)
EU
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 9.9M | 11.95M | 7.24M | 7.63M | 13.53M | 48.55M | 55.29M | 52.56M |
Total Current Assets | 8.86M | 10.84M | 6.43M | 7.22M | 13.1M | 34.78M | 9.07M | 3.84M |
Cash and Equivalents | 749k | 2.15M | 1.42M | 1.3M | 10.07M | 16.25M | 43k | 887k |
Total Non-Current Assets | 1.82M | 1.12M | 2.44M | 1.76M | 10.02M | 43.9M | 50.17M | 47.53M |
Total Liabilities | 8.08M | 10.83M | 4.8M | 5.87M | 3.51M | 4.65M | 5.13M | 5.03M |
Total Current Liabilities | 7M | 8.17M | 4.74M | 4.73M | 2.43M | 4.65M | 5.12M | 3.72M |
Total Non-Current Liabilities | 1.88M | 5.11M | 127k | 1.2M | 1.16M | 0 | 4k | 1.32M |
Total Equity | 1.82M | 1.12M | 2.44M | 1.76M | 10.02M | 43.9M | 50.17M | 47.53M |
Common Equity | 6.67M | 10.47M | 16.26M | 7.96M | 675k | 1.99M | 121k | 351k |
Retained Earnings | -82.7M | -97.54M | -108.32M | -101.45M | -93.96M | -93.22M | -89.63M | -94.6M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.